Patent Issued for Kit, device, and method for detecting lung cancer (USPTO 12043872).

Toray Industries Inc. has been granted a patent for a kit, device, and method to detect lung cancer. The patent provides background information on lung cancer and its different tissue types. The inventors aim to identify a new tumor marker for lung cancer that can be used in initial tests and offer an effective method for detecting the disease using specific nucleic acids. The patent claims a method to detect and treat lung cancer by determining the expression level of hsa-miR-4730 in a sample from a human subject, such as blood, serum, or plasma. Treatment options include chemotherapy, radiotherapy, immunotherapy, molecular targeted therapy, surgery, or a combination of these. The patent also describes a method to detect lung cancer using specific nucleotide sequences, measuring the expression levels of certain microRNAs associated with the disease. The measurement can be done using quantitative RT-PCR or hybridization techniques. The patent also mentions other microRNAs that can be measured to determine the expression levels of additional lung cancer markers. Overall, this patent provides a kit, device, and method for detecting lung cancer. [Extracted from the article]